In millions, except per share items | Dec-31-22 | Dec-31-21 |
| 10-K | 10-K |
Operating activities | | |
Net loss | | |
Adjustments to reconcile consolidated net loss to net cash used in operating activities | | |
Depreciation and amortization | | |
Amortization of intangible assets | | |
Amortization of right of use asset | | |
Deferred income taxes | | |
Provision for bad debt expense | | |
Stock-based compensation expense | | |
Gain on change in fair value of earnout payable | | |
(Gain) loss on foreign currency transactions | | |
Loss on change in fair value of derivative liability | | |
Impairment of goodwill | | |
Other | | |
Change in operating assets and liabilities: | | |
Accounts receivable and other receivables | | |
Prepaid expenses and other current assets | | |
Other assets | | |
Accounts payable | | |
Accrued liabilities | | |
Income tax liabilities | | |
Operating lease liabilities | | |
Deferred revenue | | |
Net cash used in operating activities | | |
Investing activities | | |
Purchases of property and equipment | | |
Investment in capitalized software | | |
Cash acquired in connection with Business Combination | | |
Net cash provided by (used in) investing activities | | |
Financing activities | | |
Net equity investment from parent | | |
Taxes paid related to stock-based compensation | | |
Repayment of CXApp acquisition liability | | |
Repayment of related party promissory note | | |
Net cash (used in) provided by financing activities | | |
Effect of exchange rate changes on cash and cash equivalents | | |
Net increase in cash and cash equivalents | | |
|
Supplemental disclosures of cash flow information | | |
Cash paid for taxes | | |
Cash paid for interest | | |
Supplemental schedule of noncash investing and financing activities | | |
Right of use asset obtained in exchange for lease liability | | |
Parent’s common shares issued for CXApp earnout | | |
Noncash investment from parent | | |
Class A Common Stock and Class C Common Stock issued in connection with Business Combination | | |
Financing of Director and Officer Insurance (see Note 9) | | |